Results from a study presented at the American Society of Clinical Oncology meeting in Atlanta find that modafinil, a drug used to treat narcolepsy, improved the quality of life in malignant brain tumor patients, an article in the HealthDay Reporter said.
The study examined 30 patients with various types primary brain tumors. Most the patients also experienced memory, fatigue, and attention complications. After taking a designated dose of modafinil daily for 8 weeks, most participants showed improvements in cognitive ability (21% average improvement), mood (35% average improvement), and fatigue (47% average improvement), the report said.
